Do France, Germany, and Italy agree on the added therapeutic value of medicines?

17 August 2023 - The Health Technology Assessment of medicines is performed separately at the country level with some differences, but ...

Read more →

Access and availability: Why are Europeans finding it hard to get the new medicines they need?

27 July 2023 - Patients are struggling to get hold of the new medicines they desperately need and ask what ...

Read more →

EU-HTA: G-BA coordinates parallel scientific consultations for manufacturers from September

3 July 2023 - From 2025, a systematic evaluation of clinical studies for new medicinal products and medical devices will ...

Read more →

Planned revision of EU pharmaceutical legislation: early market access and robust evidence need not remain a contradiction in terms

13 June 2023 - On 26 April, the EU Commission presented a proposal for the revision of pharmaceutical legislation in ...

Read more →

Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement

11 April 2023 - The aims of this study were to review the current interactions within and across regulatory and HTA ...

Read more →

The EU butts heads with big pharma to make medicines cheaper

2 February 2023 - The bloc’s pharma reform aims to get new drugs to patients faster, for less money. But it ...

Read more →

The battle over European drug pricing

19 January 2023 - UK and EU must balance health cost control with plans to grow life sciences. ...

Read more →

Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe

16 January 2023 - Bayer has said it is shifting the focus of its pharmaceutical business to the US and ...

Read more →

Differences in evidentiary requirements between European Medicines Agency and European health technology assessment of oncology drugs—can alignment be enhanced?

5 December 2022 - National health technology assessments across Europe show differences in evidentiary requirements from assessments by the EMA, affecting ...

Read more →

The EU HTA regulation: a new frontier for access to innovative technologies

23 August 2022 - A new health technology regulation is due to be applied to help EU countries determine the effectiveness ...

Read more →

European Union regulation of health technology assessment: what is required for it to succeed?

22 July 2022 - After considerable discussion and debate, the European Commission proposal for the regulation of health technology assessment was ...

Read more →

EU HTA regulation: international preparatory meeting in Cologne

17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...

Read more →

EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness

26 May 2022 - The objective of the European Network for Health Technology Assessment (EUnetHTA) Joint Action 3 (JA3) was to ...

Read more →

European collaboration on health technology assessment: looking backward and forward

19 April 2022 - The establishment of health technology assessment has been an important topic in Europe for many years. ...

Read more →

Europe’s new HTA system spurs more debate, concern

12 April 2022 - Fresh round of discussions around health technology assessment. ...

Read more →